Skip to main content
Siddhartha Ganguly, MD, Hematology, Houston, TX

Siddhartha Ganguly MD FACP

Hematologic Oncology


Associate Director for Clinical Investigation and Research Chief, Division of Hematology. Houston Methodist Hospital and Neal Cancer Center, Houston, TX

Telehealth Available

Request Appointment
  • 6445 Main St# OpcHouston, TX 77030

  • Book by Phone+1(346) 598-5182

  • Fax+1 713-793-1642

Overview of  Dr. Ganguly

Dr. Siddhartha Ganguly is a hematologist in Houston, TX and is affiliated with Houston Methodist Hospital. He received his medical degree from Medical College and Hospital Kolkata and has been in practice for over 30 years. He specializes in hematologic oncology and is experienced in bone marrow transplantation, multiple myeloma, lymphoma, and cellular immunotherapy. He has more than 150 publications and over 500 citings. He has been PI for many clinical trials and is the Associate Director for Clinical Investigation at the Houston Methodist Hospital and Neal Cancer Center.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1994 - 1995
  • Southern Illinois University
    Southern Illinois UniversityInternship, Internal Medicine, 1993 - 1994
  • Medical College and Hospital Kolkata
    Medical College and Hospital KolkataClass of 1987
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Hematology

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1999 - Present
  • TX State Medical License
    TX State Medical License 2020 - 2026
  • KS State Medical License
    KS State Medical License 1995 - 2025
  • WA State Medical License
    WA State Medical License 1995 - 2010
  • IL State Medical License
    IL State Medical License 1993 - 1996
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2007
  • Outstanding Teacher Award University of Kansas Medical Center, 2005
  • Max S. Allen Clinical Scholar Award University of Kansas Medical Center, 2004
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Erythropoietin modulation is associated with improved homing and engraftment post umbilical cord blood transplantation  
    Aljitawi OS, Paul S, Ganguly A, Lin TL, Ganguly S, Vielhauer G, Capitano ML, Cantelina A, Lipe B, Mahnken JD, Wise A, Berry A, Singh AK, Shune L, Lominska C, Abhyankar..., Blood, 1/19/2016
  • Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors  
    Abraham S. Kanate, Alberto Mussett, Mohamed A. Kharfan-Dabaja, Kwang W. Ahn, Alyssa DiGilio,Amer Beitinjaneh , Saurabh Chhabra, Timothy S. Fenske, Cesar Freytes, Rober..., Blood, 1/18/2016
  • Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis  
    Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kumar S, Kyle R, Lazarus HM, Lee C..., Biol Blood Marrow Transplant, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Characterization of Response and Transfusion Independence in Patients with FLT3-Internal Tandem Duplication (FLT3-ITD)_Mutated Relapsed/Refractory Acute Myeloid Leukem...
    Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
    Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Preclinical Evaluation of Gilteritinib on NPM1-ALK Driven Anaplastic Large Cell Lymphoma Cells
    Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Disparities in Multiple Myeloma Care in Rural America 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Immunotherapy and targeted therapy 
    Joplin, MO - 1/28/2016
  • Join now to see all

Other

  • Cytogenetics in Hematology 
    Siddhartha Ganguly
    1/1/2014
  • Bone Marrow Transplant Algorithm and Standard Operating Procedure 
    Siddhartha Ganguly
    1/1/2011
  • Blood and Lymph Module, Formative and Summative quiz, PBL, Small Group Discussion 
    Siddhartha Ganguly
    1/1/2009
  • Join now to see all

Press Mentions

  • Innovative Allogeneic CAR T Cell Therapy Trial Shows Promising Results
    Innovative Allogeneic CAR T Cell Therapy Trial Shows Promising ResultsMarch 27th, 2025
  • WJMSC‐Derived Small Extracellular Vesicle Enhance T Cell Suppression Through PD‐L1
    WJMSC‐Derived Small Extracellular Vesicle Enhance T Cell Suppression Through PD‐L1February 8th, 2021

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Altius Provider Directory
    BCBS Blue Card PPO
    BCBS Kansas City Preferred-Care Blue PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: